Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. NeuroSense Therapeutics Ltd’s current trading price is -58.46% away from its 52-week high, while its distance from the 52-week low is 80.45%. The stock’s price range over this period has fluctuated between $0.60 and $2.60. The company, operating within the financial sector, had a trading volume of approximately 1.58 million for the day, which was noticeably higher than the average daily share volume of 0.31 million over the last 3 months.
The stock price for NeuroSense Therapeutics Ltd (NRSN) currently stands at $1.08. The stock experienced a substantial increase in the last session, hitting $14.0 after starting at $1.08. The stock’s lowest price was $7.5 before closing at $1.8.
NeuroSense Therapeutics Ltd experienced a rather shaky stock market performance.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
NeuroSense Therapeutics Ltd (NRSN) has experienced a quarterly rise of 4.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 25.91M and boasts a workforce of 15 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.5070, with a change in price of -0.0023. Similarly, NeuroSense Therapeutics Ltd recorded 266,094 in trading volume during the last 100 days, posting a change of -0.21%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for NRSN stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.00.
NRSN Stock Stochastic Average
Today, NeuroSense Therapeutics Ltd’s raw stochastic average for the past 50 days stands at 5.00%, indicating a decline from the raw stochastic average of the last 20 days, which was 6.72%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 12.91% and 17.61% respectively.
NRSN Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 49.75%. However, over the past six months, we’ve seen a weaker performance of 1.89%. The price of NRSN leaped by -43.16% over the last 30 days. And in the last five days, it has fallen by -46.80%.
